Neumora Therapeutics
NMRA
NMRA
99 hedge funds and large institutions have $41.2M invested in Neumora Therapeutics in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
-16
Holders Change %
-13.91%
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
25
Increased
28
Reduced
28
Closed
40
Calls
$143K
Puts
$54K
Net Calls
+$89K
Net Calls Change
-$63K
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
+$772K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$526K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$473K |
| 4 |
Millennium Management
New York
|
+$376K |
| 5 |
AC
AlphaCore Capital
La Jolla,
California
|
+$248K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.55M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.8M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.01M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$777K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$585K |
